Vimarsana
Biggest News Aggregation in the World

Frankd Yocca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Frankd Yocca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Frankd Yocca Today - Breaking & Trending Today

Sublingual Dexmedetomidine May Rapidly Calm Bipolar Agitation - Vimarsana News

Sublingual Dexmedetomidine May Rapidly Calm Bipolar Agitation

Published: February 28, 2022

An investigational, self-administered, orally dissolving film formulation of dexmedetomidine rapidly relieves agitation in patients with bipolar disorder, new research suggests.

Source: medscape.com
Related Topics:
National Institutes Of HealthUnited StatesJohnk HsiaoSheldonh PreskornFrankd YoccaAmerican Psychiatric AssociationDrug AdministrationBehavioral SciencesDepartment Of PsychiatryJournal Of The American Medical AssociationUniversity Of Kansas School MedicineBioxcel TherapeuticsKansas SchoolMedscape MedicalAmerican MedicalMedscape Medical NewsNegative Syndrome Scale Excited ComponentNational InstitutesXcel TherapeuticsPrescription Drug User Fee ActBipolar DisorderBipolar ManiaManic DepressionIpolar Affective DisorderEpression Manic
BioXcel Therapeutics Announces Journal of the American - Vimarsana News

BioXcel Therapeutics Announces Journal of the American

Published: February 22, 2022

BXCL501 demonstrated statistically significant and clinically meaningful improvements in primary and key secondary efficacy measures compared with placebo ...

Source: globenewswire.com
Related Topics:
United StatesSheldonh PreskornFrankd YoccaBioxcel Therapeutics IncBehavioral SciencesDepartment Of PsychiatryJournal Of The American Medical AssociationUniversity Of Kansas School MedicineXcel TherapeuticsAmerican Medical AssociationSublingual DexmedetomidineAcute Agitation Associated With Bipolar DisorderRandomized ClinicalKansas SchoolNegative Syndrome Scale Excited ComponentChief Scientific OfficerBipolar DisorderNegative Syndrome ScaleBreakthrough TherapyFast TrackBioxcel TherapeuticsXcel TherapeuticNasdaq BtaiBioxcel Therapeutics